ubenimex has been researched along with Leukemia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamatani, S; Imai, T; Isobe, K; Itoh, S; Kuromi, T; Nanba, M; Nomi, K; Okada, H | 1 |
| Kurita, S; Massaoka, T; Ogawa, N; Ota, K; Uzuka, Y; Yamada, K | 1 |
| Arimori, S; Komatsuda, M; Nagao, T; Shimizu, Y; Watanabe, K | 1 |
| Abe, F; Fujii, H; Sekine, K | 1 |
| Hatake, K; Hayasawa, H; Ikeda, K; Ishizaka, Y; Katsuyama, M; Matsumoto-Mishima, Y; Mishima, Y; Mizunuma, N; Mori, M; Terui, Y; Watanabe, J; Yamada, M | 1 |
| Ota, K; Uzuka, Y | 1 |
| Chiba, S; Hino, M; Kitamura, T; Miyagawa, K; Miyazano, K; Shibuya, K; Takaku, F | 1 |
| Fukutani, H; Kimura, I; Miura, Y; Mizoguchi, H; Naoe, T; Ohno, R; Ohshima, T; Omine, M; Saito, H; Tomonaga, M | 1 |
| Abe, K; Imamura, M; Kasai, M; Kobayashi, M; Morioka, M; Okabe, M; Sakurada, K; Sugiura, T; Tachibana, N; Tanaka, M | 1 |
| Hiraoka, A | 1 |
| Tsukagoshi, S | 1 |
| Kurita, S; Masaoka, T; Ogawa, N; Ota, K; Uzuka, Y; Yamada, K | 2 |
1 review(s) available for ubenimex and Leukemia
| Article | Year |
|---|---|
Clinical trials of bestatin for leukemia and solid tumors.
Topics: Humans; Immunologic Factors; Leucine; Leukemia; Neoplasms | 1992 |
5 trial(s) available for ubenimex and Leukemia
| Article | Year |
|---|---|
[Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Female; Humans; Leucine; Leukemia; Male; Middle Aged | 1984 |
Clinical trials of bestatin for leukemia and solid tumors.
Topics: Humans; Immunologic Factors; Leucine; Leukemia; Neoplasms | 1992 |
Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex).
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aminopeptidases; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Child; Female; Humans; Leucine; Leukemia; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies | 1991 |
Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Humans; Leucine; Leukemia; Leukemia, Myeloid; Male; Middle Aged; Random Allocation | 1986 |
[Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Topics: Aclarubicin; Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leucine; Leukemia; Mercaptopurine; Middle Aged; Naphthacenes; Prednisolone; Prognosis; Random Allocation | 1986 |
8 other study(ies) available for ubenimex and Leukemia
| Article | Year |
|---|---|
Induction of graft-versus-host disease and a graft-versus-leukemia effect using ubenimex in a patient with infantile leukemia relapsing after an unrelated cord blood transplant.
Topics: Cord Blood Stem Cell Transplantation; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Infant; Leucine; Leukemia; Male; Recurrence; Remission Induction; Transplantation, Homologous | 2002 |
The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Leucine; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged | 1980 |
Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines.
Topics: Aminopeptidases; Apoptosis; Caspase 3; Caspases; CD13 Antigens; Cell Division; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; Leucine; Leukemia; Protease Inhibitors; Tumor Cells, Cultured | 1999 |
Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Blotting, Northern; CD13 Antigens; Cell Division; Cells, Cultured; Endothelium, Vascular; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Interleukin-8; K562 Cells; Leucine; Leukemia; Transfection; Umbilical Veins | 2002 |
Enhancing effect of ubenimex (bestatin) on proliferation and differentiation of hematopoietic progenitor cells, and the suppressive effect on proliferation of leukemic cell lines via peptidase regulation.
Topics: Aminopeptidases; Animals; Antibiotics, Antineoplastic; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leucine; Leukemia; Mice | 1991 |
Inhibitory effect of bestatin on the growth of human leukemic cells.
Topics: Antibiotics, Antineoplastic; B-Lymphocytes; Cell Division; Dose-Response Relationship, Drug; Humans; Leucine; Leukemia; Microscopy, Electron, Scanning; T-Lymphocytes; Tumor Cells, Cultured | 1990 |
[Control of graft-vs-host disease].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Female; Graft vs Host Disease; Guanidines; Humans; Leucine; Leukemia; Male; Methylprednisolone; Ribonucleosides | 1990 |
[A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Animals; Female; Humans; Leucine; Leukemia; Leukemia P388; Leukemia, Myeloid; Lymphoma; Male; Mice; Middle Aged; T-Lymphocytes | 1987 |